As Recipharm continues to refine its footprint, the CDMO is selling its development and small-scale active pharmaceutical ingredient (API) manufacturing facility in Yavne, Israel, to Scinai ...
CDMO company Cambrex completed the second phase of an expansion at its Snapdragon Chemistry API production facility in Waltham, Massachusetts. The project added 51,000 square feet to the facility’s ...
"We are very excited to transition this fully-integrated API Pharmaceutical site, with its substantial reaction capacity, site infrastructure and attractive location, we are confident in the potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results